摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4,4,5,5-pentamethyl-1-hydroxy-2-imidazoline | 402520-12-1

中文名称
——
中文别名
——
英文名称
2,4,4,5,5-pentamethyl-1-hydroxy-2-imidazoline
英文别名
2,4,4,5,5-pentamethyl-4,5-dihydroimidazol-1-ol;2,4,4,5,5-pentamethyl-4,5-dihydro-1H-imidazol-1-ol;2,4,4,5,5-pentamethyl-4,5-dihydro-1H-imidazolyl-1-oxide;2,4,4,5,5-Pentamethyl-4,5-dihydro-1h-imidazole 3-oxide;1-hydroxy-2,4,4,5,5-pentamethylimidazole
2,4,4,5,5-pentamethyl-1-hydroxy-2-imidazoline化学式
CAS
402520-12-1
化学式
C8H16N2O
mdl
——
分子量
156.228
InChiKey
RSZMPTDVFRCRLX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    211.7±23.0 °C(Predicted)
  • 密度:
    1.02±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    35.8
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A New Class of Enehydroxylamino Ketones− (R)-2-(1-Hydroxy-4,4,5,5-tetraalkylimidazolidin-2-ylidene)ethanones: Synthesis and Reactions
    作者:Vladimir A. Reznikov、Galina I. Roshchupkina、Dmitrii G. Mazhukin、Pavel A. Petrov、Sergei A. Popov、Sergey V. Fokin、Galina V. Romanenko、Tatjana V. Rybalova、Yuri V. Gatilov、Yuri G. Shvedenkov、Irina G. Irtegova、Leonid A. Shundrin、Victor I. Ovcharenko
    DOI:10.1002/ejoc.200300536
    日期:2004.2
    Three approaches to the synthesis of (R)-2-(1-hydroxy-4,4,5,5-tetraalkylimidazolidin-2-ylidene)ethanones 1 are described: (a) condensation of 1,2-bishydroxylamines with β-ketoaldehyde synthons, (b) treatment of metallated 1-hydroxy-2-methyl-4,5-dihydroimidazoles with esters, and (c) 1,3-dipolar cycloaddition between 1-hydroxy-4,5-dihydroimidazole-3-oxide and DMAD. The reactivity of 1 with electrophiles
    描述了合成 (R)-2-(1-羟基-4,4,5,5-四烷基咪唑烷-2-亚基) 乙酮 1 的三种方法:(a) 1,2-双羟胺与 β-酮醛的缩合合成子,(b) 用酯处理金属化 1-羟基-2-甲基-4,5-二氢咪唑,和 (c) 1-羟基-4,5-二氢咪唑-3-氧化物和 DMAD 之间的 1,3-偶极环加成. 已经研究了 1 与亲电试剂的反应性。环外亚甲基(烯胺)碳原子被证明是亲电攻击的主要位点。合成的氯取代 1-羟基-2-乙炔咪唑烷与氰化钠反应形成相应的腈。这些腈的氧化伴随着持久性乙烯基氮氧化合物的形成而发生,它们作为潜在的顺磁性配体是令人感兴趣的。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany,
  • 1,3-Dipolar cycloaddition or nucleophilic addition: Influence of solvents and nature of substituents in the reagent and substrate molecules on the reaction of 4,5-dihydro-1<i>H</i>-imidazole 3-oxides with alkynes
    作者:Sergey A. Popov、Vladimir A. Reznikov
    DOI:10.1002/jhet.5570430207
    日期:2006.3
    Two competitive processes - 1,3-dipolar cycloaddition and nucleophilic addition - in the reaction of 4,4,5,5-tetramethyl-4,5-dihydro-1H-imidazole 3-oxides with asymmetrically substituted alkynes were shown to occur. The influence of solvents and the nature of substituents in the reagent and substrate molecules on the rate ratio of these competitive processes were studied.
    在4,4,5,5-四甲基-4,5-二氢-1 H-咪唑3-氧化物与不对称取代的炔烃的反应中,发生了两个竞争过程-1,3-偶极环加成和亲核加成。研究了溶剂以及试剂和底物分子中取代基的性质对这些竞争过程的速率比的影响。
  • Aminonitrone-N-hydroxyaminoimine tautomeric equilibrium in the series of 1-hydroxy-2-imidazolines
    作者:Sergey A. Popov、Rodion V. Andreev、Galina V. Romanenko、Viktor I. Ovcharenko、Vladimir A. Reznikov
    DOI:10.1016/j.molstruc.2004.02.028
    日期:2004.7
    A series of 2-substituted 1-hydroxy-4,4,5,5-tetramethyl-4,5-dihydro-1H-imidazoles have been synthesized. Various effects on the state of the aminonitrone-N-hydroxyaminoimine tautomeric equilibrium, including solvent effects and substituent effect in the 2 position of heterocycle, have been studied. (C) 2004 Elsevier B.V. All rights reserved.
  • Coordination chemistry of the nitronyl and imino nitroxides. Linear chain adducts with rhodium(II) trifluoroacetate dimer
    作者:Andre Cogne、Andre Grand、Paul Rey、Robert Subra
    DOI:10.1021/ja00191a020
    日期:1989.4
  • BIRADICAL POLARIZING AGENTS FOR DYNAMIC NUCLEAR POLARIZATION
    申请人:Griffin Robert G.
    公开号:US20090302842A1
    公开(公告)日:2009-12-10
    The present invention provides methods for performing dynamic nuclear polarization using biradicals with a structure of formula (I) as described herein. In general, the methods involve (a) providing a frozen sample in a magnetic field, wherein the frozen sample includes a biradical of formula (I) and an analyte with at least one spin half nucleus; (b) polarizing the at least one spin half nucleus of the analyte by irradiating the frozen sample with radiation having a frequency that excites electron spin transitions in the biradical; (c) optionally melting the sample to produce a molten sample; and (d) detecting nuclear spin transitions in the at least one spin half nucleus of the analyte in the frozen or molten sample. The present invention also provides biradicals with a structure of formula (I) with the proviso that Q 1 and Q 2 are different when X 1 and X 2 are —O—. The present invention also provides methods for making biradicals with a structure of formula (IA) as described herein.
查看更多

同类化合物

辛基羟乙基咪唑啉 辛基羟乙基咪唑啉 肉豆蔻基羟乙基咪唑啉 甲基-(1-甲基-吡咯烷-2-亚基)-胺 甲基(5-甲基-1,2-恶唑-3-基)氨基甲酸酯 油基胺乙基咪唑啉 氯代醋酸钠与4,5-二氢-十一烷基-1H-咪唑-1-乙醇和氢氧化钠的反应产物 月桂基羟乙基咪唑啉 恶唑-4-基氨基甲酸叔丁酯 异硬脂基羟乙基咪唑啉 异噁隆 异丙基亚氨基吡咯烷 噻唑-2,4-二胺 噁唑-4-胺 叔-丁基2-氨基-6,7-二氢吡唑并[1,5-A]吡嗪-5(4H)-甲酸基酯 十七碳-2-烯基-4,5-二氢-1H-咪唑-1-乙醇盐酸盐 偶氮引发剂VA-064 依凡达明 二氨基吡唑 乙基3-(乙基氨基)-5-甲基-1,2-恶唑-4-羧酸酯 alpha-(氯甲基)-2-异丙基-5-硝基-2H-咪唑-2-乙醇 alpha,4,4-三甲基-2-十一烷基-2-咪唑啉-1-乙醇 Z-2-(8-十七烯基)-4,5-二氢-1H-咪唑-1-乙醇 N-甲基-3-氨基吡唑 N-甲基-2-吡咯烷酮肟 N-甲基-1,2-噻唑-3-胺1,1-二氧化物 N-环己基-1,2-噻唑-3-胺1,1-二氧化物 N-叔-丁基-5-甲基-2H-吡唑-3-胺 N-乙基-N-(5-甲基-3-异恶唑基)-乙酰胺 N-乙基-1,2-噻唑-3-胺1,1-二氧化物 N-乙基-1,2,5-恶二唑-3,4-二胺 N-[2-[2-[(E)-十七碳-8-烯基]-4,5-二氢咪唑-1-基]乙基]乙烷-1,2-二胺 N-[2-[2-(13-二十一碳烯-1-基)-4,5-二氢-1H-咪唑-1-基]乙基]乙二胺 N-[2-(4,5-二氢-2-十九烷基-1H-咪唑-1-基)乙基]乙二胺 N-[2-(4,5-二氢-2-十一烷基-1H-咪唑-1-基)乙基]乙二胺 N-[(2Z)-哌嗪-2-亚基]-2,2,2-三氟乙酰肼 N-[(2-甲基苯基)氨基甲硫杂酰]-2-(4-羰基-2-苯基喹唑啉-3(4H)-基)-3-苯基丙酰胺 N-BOC-4-氨基噻唑 N-3-异恶唑氨基甲酸叔丁酯 N-(噻二唑-4-基)氨基甲酸乙酯 N-(5-叔丁基-1H-吡唑-3-基)氨基甲酸甲酯 N-(4,5-二甲基-3-异噁唑)氨基甲酸1,1-二甲基乙酯 N-(2-氨基乙基)-N'-[2-[2-(13-二十一碳烯基)-4,5-二氢-1H-咪唑-1-基]乙基]乙二胺 N-(2-氨基乙基)-N'-[2-(4,5-二氢-2-十九烷基-1H-咪唑-1-基)乙基]乙二胺 N-(2-氨基乙基)-N'-[2-(2-十七烷基-4,5-二氢-1H-咪唑-1-基)乙基]乙二胺 N,N,N',N'-四甲基-4,6-二(三甲基硅烷基)环戊二烯并[c]吡咯-1,3-二胺 N,N,N',N',5-戊甲基环戊并[c]吡咯-1,3-二胺 N,N,3,3-四甲基氮杂环丙烯-2-胺 N,5-二甲基-1,2-恶唑-3-胺 6H-吡唑并[1,5-c][1,2,3]三唑-3,5,6-三胺